• ozi1
  • ozi2
  • ozi3
  • Ezigbo otu

    Ezigbo otu

    3 agadi R&D dọkịta
    5 agadi ndị ndụmọdụ mba ofesi
    Ihe karịrị 80 teknụzụ na-akwụ ụgwọ dị elu
    Otu R&D
  • Otutu Platform

    Otutu Platform

    Mmadụ, anụmanụ, anụ ụlọ
    ELISA/GICT/IFA/CLIA ikpo okwu
    Ngwa nyocha ngwa ngwa 70+ mmadụ
    Ngwa nyocha anụmanụ 30+
  • Ike mmepụta

    Ike mmepụta

    Mpaghara 5000 square mita
    Ebe a kwadebere nke ọma
    100,000 larịị isi ọcha
    Ahịrị mmepụta ihe dị elu
  • Ntụkwasị obi ịdị mma

    Ntụkwasị obi ịdị mma

    CE akwụkwọ ikike
    ISO 13485 àgwà usoro asambodo
    ahaziri SOP
    mmepụta / njikwa
  • ozi4
  • ozi5
  • ozi6

E hiwere BOTAL na 2018, yana isi ụlọ ọrụ ya dị na Ningbo City, China, yana ụlọ ọrụ teknụzụ dị elu nwere teknụzụ immunodiagnostic dị ka isi na ijikọ R&D, mmepụta na ire ahịa.
N'ịdabere na teknụzụ akụrụngwa akụrụngwa n'onwe ya mepụtara ma mepụta ya site na antigen na mgbochi, yana ikpo okwu ELISA tozuru oke, ikpo okwu GICT, ikpo okwu IFA na ikpo okwu CLIA, BOTAI ewepụtala ma guzobe POCT reagents na mpaghara asaa isi na-ekpuchi nchọpụta ọrịa na-efe efe, vector. -amụ ọrịa nchọpụta, akụkụ okuku ume ọrịa nchọpụta mbufụt nchọpụta, tumor nchọpụta, zoonotic ọrịa detectionand anụmanụ (anụmanụ / akụ na ụba) ọrịa screening, na ugbu a kpụrụ omimi nke ulo oru yinye si upstream isi akụrụngwa na diagnostic reagents.Serving more than 150 obodo na mpaghara gburugburu ụwa.

  • ihe ngosi5
  • ihe ngosi6
  • ngosi
  • ihe ngosi2
  • ihe ngosi3
  • ihe ngosi4

Hapụ Ozi Gị